Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet.

Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored.

You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://thinkipstrategy.com/subscribe/

US: Reps Eshoo, Inslee and Barton introduce Pathway for Biosimilars Act (FDA Law Blog) (Patent Docs) (Patent Baristas) (Patent Baristas) (Law360)

US: Reps Waxman, Pallone, Deal and Emerson introduce Promoting Innovation and Access to Life-Saving Medicine Act (Intellectual Property Watch) (IPKat) (Patent Docs)

EU: Pharma submissions relating to pharma sector inquiry now available on European Commission’s website (IPKat)

World Health Organisation issues statement on generic drug seizures (Intellectual Property Watch)

New thinking on biotech patents from industry groups (Intellectual Property Watch)

Universities, pharma giants striking more deals for basic research (Technology Transfer Tactics)

Merck buys Schering-Plough: Some ruminations (IP finance)

Roche and Genentech: The knot is nearly tied (IP finance)

New medical technologies bring new IP challenges (Intellectual Property Watch)

Africa: Kenya Conference – Financial incentives needed for tailored neglected disease research (Intellectual Property Watch)

Brazil: Patentability of polymorphs (IP tango)

EU: Pharma submissions relating to pharma sector inquiry now available on European Commission’s website  (IPKat)

EU: European Generic Medicines Association opposes zero- and negative-term SPCs (The SPC Blog)

India / Netherlands / Nigeria: Dutch officials seize consignment of HIV/AIDS medicines by Aurobindo meant for use in Nigeria (Spicy IP)

US: CAFC: Foreign regulatory submission invalidates patent under 102(b): In re Natures Remedies (not precedential) (Patently-O) (Patent Prospector) (Hal Wegner)

US: Life Technologies seeks to invalidate Oxford Biomedical Research patent covering method of purification for cytochrome P450 proteins (Patent Docs)

US: Breckenridge loses suit to invalidate Everett patent for prescription multivitamin due to lack of subject matter (Patent Docs) (Law360)

US: Wyeth files suit against Intervet and Boeringer Ingelheim Vetmedica alleging infringement of patents covering treatment for Porcine Circovirus, piglet weight loss disease (The Prior Art)

US: AsymmetRx and Harvard University file patent infringement suit against Dako Denmark over diagnostic test kit for prostate cancer (Law360)

US: BIO seeks improvement to patent reform legislation (Patent Docs)

US: Senate and House introduce bills prohibiting authorised generics: Preserve Access to Affordable Generics Act, Promoting Innovation and Access to Life-Saving Medicine Act, Patent Reform Act (Patent Docs)

US: Reps Eshoo, Inslee and Barton introduce Pathway for Biosimilars Act (FDA Law Blog) (Patent Docs) (Patent Baristas) (Patent Baristas) (Law360)

US: Reps Waxman, Pallone, Deal and Emerson introduce Promoting Innovation and Access to Life-Saving Medicine Act (Intellectual Property Watch) (IPKat)

US: AIPLA names HP&M attorney to chair Hatch-Waxman Group (FDA Law Blog)

Copaxone (Glatiramer acetate) – India: Natco successfully opposes patent application covering Teva’s Copaxone (GenericsWeb)

Doryx (Doxycycline) – US: Warner Chilcott files new lawsuit against Impax for infringement of Doryx patent (SmartBrief) (Law360) (GenericsWeb)

Eloxatin (Oxaliplatin) – US: Patent infringement suit launched following Para IV certification as part of generic Eloxatin ANDA: Sanofi-Aventis US LLC et al v Ebewe Pharma Ges MBH NFG.KG (Patent Docs)

Evoclin (Clindamycin) – US: Steifel sues Cobrek, Perrigo over generic Evoclin (Law360) (GenericsWeb)

Fosrenol (Lanthanum carbonate) – US: Shire files patent infringement suit against Barr Lab’s over generic Fosrenol ANDA (SmartBrief) (SmartBrief) (Law360)

Kaletra (Lopinavir) – US: Abbott Lab’s sues Mylan for infringement of two patents related to Kaletra (GenericsWeb)

Oxycodone – US: CAFC finds oxycodone method obvious: Robert Chapman v Michael Casner (Law360)

Prilosec (Omeprazole) – US: Dr Reddy’s wins summary judgment of non infringement against AstraZeneca in Prilosec litigation (IP Watchdog)

Renagel (Sevelamer hydrochloride) – US: Genzyme files suit against Impax over Renagel ANDA (Law360) (GenericsWeb)

Solodyn (Minocycline) – US: Teva and Medicis announce settlement agreement relating to Solodyn (SmartBrief) (Law360)

Xopenex (Levosalbutamol) – US: Sepracor settles Xopenex suit with Barr (Patent Docs)